Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ranjani Ganapathy Subramanian"'
Autor:
Ranjani Ganapathy Subramanian, Dana Horakova, Manuela Vaneckova, Balazs Lorincz, Jan Krasensky, Eva Kubala Havrdova, Tomas Uher
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2230 (2021)
Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aimed to evaluate the effect of natalizumab on basic inflammatory CSF and
Externí odkaz:
https://doaj.org/article/0526435ba0ed4afe999b8e05c9d85b05
Autor:
Ranjani Ganapathy Subramanian, Robert Zivadinov, Niels Bergsland, Michael G. Dwyer, Bianca Weinstock-Guttman, Dejan Jakimovski
Publikováno v:
Journal of Neurology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d5bfd0c415f4fe825ee9a7ca3cd4248
https://doi.org/10.1007/s00415-023-11709-y
https://doi.org/10.1007/s00415-023-11709-y
Autor:
Jan Krasensky, Manuela Vaneckova, E. K. Havrdova, Balazs Lorincz, Dana Horáková, Tomas Uher, Ranjani Ganapathy Subramanian
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 2230, p 2230 (2021)
Diagnostics; Volume 11; Issue 12; Pages: 2230
Diagnostics, Vol 11, Iss 2230, p 2230 (2021)
Diagnostics; Volume 11; Issue 12; Pages: 2230
Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aimed to evaluate the effect of natalizumab on basic inflammatory CSF and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aefa975903779dc5bd84854fee23672
https://doi.org/10.3390/diagnostics11122230
https://doi.org/10.3390/diagnostics11122230